0.03Open0.04Pre Close3 Volume175 Open Interest74.00Strike Price11.00Turnover183.19%IV4.64%PremiumDec 13, 2024Expiry Date0.00Intrinsic Value100Multiplier0DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type-0.0533Delta0.0493Gamma1551.00Leverage Ratio-1.3022Theta0.0000Rho-82.61Eff Leverage0.0013Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet